PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day

Core Viewpoint - PROCEPT BioRobotics Corporation has updated the timing of its fourth quarter 2025 earnings conference call and Investor Day due to travel disruptions caused by inclement weather [1]. Financial Results Announcement - The Company will report its financial results for the fourth quarter of 2025 after market close on February 25, 2026, with a conference call scheduled for 4:30 p.m. Eastern Time [2]. - The in-person Investor Day event has been rescheduled to February 26, 2026, at NASDAQ Headquarters in New York City, starting at 8:00 a.m. Eastern Time [2]. Webcast Availability - A live webcast of both the earnings call and Investor Day will be available on the Company's website, with archived recordings accessible for at least 90 days post-event [3]. Company Overview - PROCEPT BioRobotics aims to revolutionize BPH treatment globally by providing advanced robotic solutions that enhance patient outcomes and deliver value [4]. - The Company manufactures the AQUABEAM® and HYDROS® Robotic Systems, with the HYDROS system being the only AI-powered technology for Aquablation therapy [4]. - Aquablation therapy is designed to provide effective and durable outcomes for men suffering from lower urinary tract symptoms due to BPH, regardless of prostate size or surgeon experience [4]. - BPH is the most common prostate disease, affecting approximately 40 million men in the United States [4].